Atlas Trials

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer

Clinical trial NCT01701349 · WITHDRAWN

Trial details

NCT number
NCT01701349
Sponsor
Mateon Therapeutics
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Anaplastic Thyroid Cancer
Start date
2015-03-01
Primary completion
2017-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.